Methods of treating homologous recombination deficient cancer | Patent Publication Number 20220048983
US 20220048983 A1Patent NumberUS 11970530 B2
Application Number17399527
Filled DateAug 11, 2021
Priority DateAug 13, 2020
Publication DateFeb 17, 2022
Original AssigneeAstrazeneca
Current AssigneeAstrazeneca
Inventor/ApplicantsERIC PUJADE-LAURAINE
ISABELLE RAY-COQUARD
TSVETA PETROVA MILENKOVA-ILIEVA
Eric Pujade-Lauraine
Isabelle Ray-Coquard
Tsveta Petrova Milenkova-Ilieva
ISABELLE RAY-COQUARD
TSVETA PETROVA MILENKOVA-ILIEVA
Eric Pujade-Lauraine
Isabelle Ray-Coquard
Tsveta Petrova Milenkova-Ilieva
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.